Analysts say Darzalex sales prognosis could be too cautious
![Photo: Tuala Hjarnø / Genmab / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13383397.ece/ALTERNATES/schema-16_9/doc7i1a4vt0dk714w5ed2v9.jpg)
The sales of Darzalex have exceeded expectations in the third quarter of the year, surpassing net sales expectations by more than DKK 850 million.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Genmab sales of Darzalex exceed expectations in Q3
For subscribers
Janssen had better Darzalex sales than expected in Q1
For subscribers